Clinical trial
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine…
NCT00329901 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00329901 |
|---|---|
| Title | Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years |
| Official title | A Phase 3, Multi-Center, Observer Blind, Controlled, Randomized Study to Compare the Immunogenicity and Safety of the Concomitant Administration of a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis (Tdap) Vaccine and Chiron (Now Novartis) Meningococcal ACWY Conjugate Vaccine, With… |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningococcal Disease, Meningococcal Meningitis |
| Intervention type | Biological |
| Interventions | Meningococcal ACWY conjugate vaccine (MenACWY-CRM), Combined tetanus, reduced diphtheria and acellular pertussis vaccine (Tdap), saline placebo |
| Enrollment | 1,072 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 25, 2006 |
| Last update posted | Jun 18, 2014 |
| Countries | Italy |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: